Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BY-NC-NDHealth science reports

Global Burden, Temporal Trends, Extrapolation Based on Past Trends, and Population Attributable Fractions of Risk Factors for Type 2 Diabetes Mellitus: An Ecological Study Based on the Global Burden of Disease Study 2021.

5 affiliations
  1. 1Non-communicable Diseases Research Center Shiraz University of Medical Sciences Shiraz Iran.
  2. 2Department of Epidemiology, School of Health Shiraz University of Medical Sciences Shiraz Iran.
  3. 3Cardivascular Research Center Shiraz University of Medical Sciences Shiraz Iran.
  4. 4Research Center for Traditional Medicine and History of Medicine Shiraz University of Medical Sciences Shiraz Iran.
  5. 5Student Research Committee Shiraz University of Medical Sciences Shiraz Iran.

Abstract

Amidst the rising global impact of type 2 diabetes mellitus (T2DM), long-term extrapolations and attributable risk estimations are essential for strategic healthcare planning. This study aimed to investigate the T2DM burden among adults aged ≥ 25 years, extrapolate trends to 2040, and quantify the population attributable fractions (PAFs) of major risk factors. We extracted the prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of T2DM from 1990 to 2021 using data from the GBD 2021 release. Joinpoint regression was used to analyze the trend in the burden of disease. Then, using the AAPC in the previous step, we extrapolated the burden indicators up to 2040. To determine the independent contribution of each risk factor to the disease burden, we calculated the adjusted PAF. All burden indicators and their extrapolations showed a significant increasing trend (p < 0.001). Globally, the prevalence of T2DM increased from 4.82% in 1990 to 10.60% in 2021. Similarly, incidence rose from 255.21 in 1990 to 463.10 per 100,000 in 2021. Mortality and DALYs rates increased from 24.35 to 34.42 per 100,000 and 945.70 to 1594.20 per 100,000, respectively, over the same period (all p < 0.001). Among the risk factors examined, based on adjusted PAF and its extrapolation, high body mass index (BMI) was the most important contributing factor (25.99% to 32.52%). The results of this study indicate that the global burden of T2DM is projected to rise significantly, and high BMI, which is associated with multiple metabolic disorders, significantly increases the risk of T2DM. Accordingly, integrating and implementing comprehensive interventions at three levels of prevention (primary, secondary, and tertiary), with a special focus on controlling and reducing obesity and overweight, is essential to control and reduce the burden of diabetes.

Related

  1. Risk of age-related macular degeneration: population-attributable fractions in 600 000 individuals without genetic information or baseline ocular phenotypes from two contemporary population-based studies
    Børge G Nordestgaard, Shoaib Afzal, Lars Michael Larsen +1
    BMJ Open OphthalmologyPeer-reviewedCC BYFull textGeneral medicineDOAJ
  2. Smoking-Attributable Mortality in China — Epidemic Stage as a Temporal Dimension in Interpreting GBD Estimates
    Gonghuan Yang, Xia Wan
    China CDC weeklyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Tobacco-attributable burden of alzheimer’s disease and other dementias in China and ASEAN : Temporal trends and projections – an observational study based on GBD 2021
    Piaoyun Wen, Wenwen Liu, Yanjiang Li +12
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Population burden of diabetes, hypertension, and cardiovascular disease attributable to obesity: a community-based study in Türkiye
    Banu Ersoy Şen, Meltem Yılmaz, Merve Taştan
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  5. Global inequalities, attributable risks, and future trends in hypertensive heart disease burden : An ecological study based on the Global Burden of Disease Study 2021, 1990–2021
    Changshun Yan, Su Hu, Hangyu Cao +5
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
BibTeX
@article{mirahmadizadeh2026global,
  title = {{Global Burden, Temporal Trends, Extrapolation Based on Past Trends, and Population Attributable Fractions of Risk Factors for Type 2 Diabetes Mellitus: An Ecological Study Based on the Global Burden of Disease Study 2021.}},
  author = {Alireza Mirahmadizadeh and Jafar Hassanzadeh and Mehrab Sayadi and Mohammad Hossein Sharifi and Zahra Jaafari},
  journal = {Health science reports},
  year = {2026},
  month = oct,
  doi = {10.1002/hsr2.73441},
  url = {https://europepmc.org/article/MED/42953516},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Global Burden, Temporal Trends, Extrapolation Based on Past Trends, and Population Attributable Fractions of Risk Factors for Type 2 Diabetes Mellitus: An Ecological Study Based on the Global Burden of Disease Study 2021.
AU  - Alireza Mirahmadizadeh
AU  - Jafar Hassanzadeh
AU  - Mehrab Sayadi
AU  - Mohammad Hossein Sharifi
AU  - Zahra Jaafari
PY  - 2026
DA  - 2026/10/28
JO  - Health science reports
DO  - 10.1002/hsr2.73441
UR  - https://europepmc.org/article/MED/42953516
AB  - Amidst the rising global impact of type 2 diabetes mellitus (T2DM), long-term extrapolations and attributable risk estimations are essential for strategic healthcare planning. This study aimed to investigate the T2DM burden among adults aged ≥ 25 years, extrapolate trends to 2040, and quantify the population attributable fractions (PAFs) of major risk factors. We extracted the prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of T2DM from 1990 to 2021 using data from the GBD 2021 release. Joinpoint regression was used to analyze the trend in the burden of disease. Then, using the AAPC in the previous step, we extrapolated the burden indicators up to 2040. To determine the independent contribution of each risk factor to the disease burden, we calculated the adjusted PAF. All burden indicators and their extrapolations showed a significant increasing trend (p < 0.001). Globally, the prevalence of T2DM increased from 4.82% in 1990 to 10.60% in 2021. Similarly, incidence rose from 255.21 in 1990 to 463.10 per 100,000 in 2021. Mortality and DALYs rates increased from 24.35 to 34.42 per 100,000 and 945.70 to 1594.20 per 100,000, respectively, over the same period (all p < 0.001). Among the risk factors examined, based on adjusted PAF and its extrapolation, high body mass index (BMI) was the most important contributing factor (25.99% to 32.52%). The results of this study indicate that the global burden of T2DM is projected to rise significantly, and high BMI, which is associated with multiple metabolic disorders, significantly increases the risk of T2DM. Accordingly, integrating and implementing comprehensive interventions at three levels of prevention (primary, secondary, and tertiary), with a special focus on controlling and reducing obesity and overweight, is essential to control and reduce the burden of diabetes.
SN  - 2398-8835
ER  -